Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 randomized placebo-controlled trial of brivaracetam adjunctive therapy for partial-onset seizures
NL-OMON31126Phase 3Active, not recruiting
- Sponsor
- UCB
- Start
- Feb 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of brivaracetam in epilepsy and Focal Onset Epilepsy (4 arms), sponsored by UCB. Primary endpoint: Primary efficacy endpoint. Started Feb 2008; status: active, not recruiting.
02
Drugs
brivaracetam
03
Conditions
epilepsyFocal Onset Epilepsy
Beyond the preview
Go deeper on NL-OMON31126.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31126.